secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ventyx Biosciences, Inc. (—)
CIK:        0001851194
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001193125-23-290726
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Ventyx Biosciences reduces workforce by ~20%, expects $2.0M severance costs
---------------------------------------------------------------------------

- Reduction in force impacts approximately 20% of the company's workforce.
- Estimated total severance and benefit expenses of $2.0 million.
- Additional charges may be incurred; details to follow in 2023 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/0001193125-23-290726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/d548412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-290726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer